BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 29097390)

  • 1. Differential Impact of Serial Measurement of Nonplatelet Thromboxane Generation on Long-Term Outcome After Cardiac Surgery.
    Kakouros N; Gluckman TJ; Conte JV; Kickler TS; Laws K; Barton BA; Rade JJ
    J Am Heart Assoc; 2017 Nov; 6(11):. PubMed ID: 29097390
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Risk Factors for Nonplatelet Thromboxane Generation After Coronary Artery Bypass Graft Surgery.
    Kakouros N; Nazarian SM; Stadler PB; Kickler TS; Rade JJ
    J Am Heart Assoc; 2016 Mar; 5(3):e002615. PubMed ID: 27068626
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Nonplatelet thromboxane generation is associated with impaired cardiovascular performance and mortality in heart failure.
    Hariri E; Kakouros N; Bunsick DA; Russell SD; Mudd JO; Laws K; Lake MW; Rade JJ
    Am J Physiol Heart Circ Physiol; 2022 Jul; 323(1):H248-H255. PubMed ID: 35714178
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Thromboxane A(2) generation, in the absence of platelet COX-1 activity, in patients with and without atherothrombotic myocardial infarction.
    DeFilippis AP; Oloyede OS; Andrikopoulou E; Saenger AK; Palachuvattil JM; Fasoro YA; Guallar E; Blumenthal RS; Kickler TS; Jaffe AS; Gerstenblith G; Schulman SP; Rade JJ
    Circ J; 2013; 77(11):2786-92. PubMed ID: 23985963
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prognostic value of urinary 11-dehydro-thromboxane B
    Vasudevan A; Tecson KM; Bennett-Firmin J; Bottiglieri T; Lopez LR; Peterson M; Sathyamoorthy M; Schiffmann R; Schussler JM; Swift C; Velasco CE; McCullough PA
    Catheter Cardiovasc Interv; 2018 Oct; 92(4):653-658. PubMed ID: 29193683
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Reduced Antiplatelet Effect of Aspirin Does Not Predict Cardiovascular Events in Patients With Stable Coronary Artery Disease.
    Larsen SB; Grove EL; Neergaard-Petersen S; Würtz M; Hvas AM; Kristensen SD
    J Am Heart Assoc; 2017 Aug; 6(8):. PubMed ID: 28780510
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Statin therapy and thromboxane generation in patients with coronary artery disease treated with high-dose aspirin.
    Bliden KP; Singla A; Gesheff MG; Toth PP; Tabrizchi A; Ens G; Guyer K; Singh M; Franzese CJ; Stapleton D; Tantry US; Gurbel PA
    Thromb Haemost; 2014 Aug; 112(2):323-31. PubMed ID: 24763965
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of aspirin response measured by urinary 11-dehydrothromboxane B2 and VerifyNow aspirin assay in patients with ischemic stroke.
    Dharmasaroja PA; Sae-Lim S
    J Stroke Cerebrovasc Dis; 2014; 23(5):953-7. PubMed ID: 24126290
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Risk stratification after coronary artery bypass surgery by a point-of-care test of platelet function.
    Bevilacqua S; Alkodami AA; Volpi E; Cerillo AG; Berti S; Glauber M; Gianetti J
    Ann Thorac Surg; 2009 Feb; 87(2):496-502. PubMed ID: 19161767
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Aspirin-resistant thromboxane biosynthesis and the risk of myocardial infarction, stroke, or cardiovascular death in patients at high risk for cardiovascular events.
    Eikelboom JW; Hirsh J; Weitz JI; Johnston M; Yi Q; Yusuf S
    Circulation; 2002 Apr; 105(14):1650-5. PubMed ID: 11940542
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Once versus twice daily aspirin after coronary bypass surgery: a randomized trial.
    Paikin JS; Hirsh J; Ginsberg JS; Weitz JI; Chan NC; Whitlock RP; Pare G; Eikelboom JW
    J Thromb Haemost; 2017 May; 15(5):889-896. PubMed ID: 28267249
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Aspirin Resistance Predicts Adverse Cardiovascular Events in Patients with Symptomatic Peripheral Artery Disease.
    Pasala T; Hoo JS; Lockhart MK; Waheed R; Sengodan P; Alexander J; Gandhi S
    Tex Heart Inst J; 2016 Dec; 43(6):482-487. PubMed ID: 28100965
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Predictors of high platelet reactivity during aspirin treatment in patients with type 2 diabetes.
    Kapłon-Cieślicka A; Rosiak M; Postuła M; Serafin A; Kondracka A; Opolski G; Filipiak KJ
    Kardiol Pol; 2013; 71(9):893-902. PubMed ID: 24065375
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Platelet reactivity and cardiovascular events after percutaneous coronary intervention in patients with stable coronary artery disease: the Stent Thrombosis In Belgium (STIB) trial.
    Legrand V; Cuisset T; Chenu P; Vrolix M; Martinez C; Dens J; Gach O; Boland J; Claeys MJ; Magne J; Barbato E; Wijns W
    EuroIntervention; 2014 Jun; 10(2):204-11. PubMed ID: 24952058
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Who might benefit from early aspirin after coronary artery surgery?
    Gukop P; Gutman N; Bilkhu R; Karapanagiotidis GT
    Interact Cardiovasc Thorac Surg; 2014 Sep; 19(3):505-11. PubMed ID: 24871533
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Three vs twelve months of dual antiplatelet therapy after zotarolimus-eluting stents: the OPTIMIZE randomized trial.
    Feres F; Costa RA; Abizaid A; Leon MB; Marin-Neto JA; Botelho RV; King SB; Negoita M; Liu M; de Paula JE; Mangione JA; Meireles GX; Castello HJ; Nicolela EL; Perin MA; Devito FS; Labrunie A; Salvadori D; Gusmão M; Staico R; Costa JR; de Castro JP; Abizaid AS; Bhatt DL;
    JAMA; 2013 Dec; 310(23):2510-22. PubMed ID: 24177257
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Duration of dual antiplatelet therapy after implantation of drug-eluting stents.
    Park SJ; Park DW; Kim YH; Kang SJ; Lee SW; Lee CW; Han KH; Park SW; Yun SC; Lee SG; Rha SW; Seong IW; Jeong MH; Hur SH; Lee NH; Yoon J; Yang JY; Lee BK; Choi YJ; Chung WS; Lim DS; Cheong SS; Kim KS; Chae JK; Nah DY; Jeon DS; Seung KB; Jang JS; Park HS; Lee K
    N Engl J Med; 2010 Apr; 362(15):1374-82. PubMed ID: 20231231
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical outcome after surgical or percutaneous revascularization in coronary bypass graft failure.
    Harskamp RE; Beijk MA; Damman P; Kuijt WJ; Woudstra P; Grundeken MJ; Kloek JJ; Tijssen JG; de Mol BA; de Winter RJ
    J Cardiovasc Med (Hagerstown); 2013 Jun; 14(6):438-45. PubMed ID: 22828774
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Differential Event Rates and Independent Predictors of Long-Term Major Cardiovascular Events and Death in 5795 Patients With Unprotected Left Main Coronary Artery Disease Treated With Stents, Bypass Surgery, or Medication: Insights From a Large International Multicenter Registry.
    Kang SH; Ahn JM; Lee CH; Lee PH; Kang SJ; Lee SW; Kim YH; Lee CW; Park SW; Park DW; Park SJ
    Circ Cardiovasc Interv; 2017 Jul; 10(7):. PubMed ID: 28701487
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Association of cyclooxygenase-1-dependent and -independent platelet function assays with adverse clinical outcomes in aspirin-treated patients presenting for cardiac catheterization.
    Frelinger AL; Li Y; Linden MD; Barnard MR; Fox ML; Christie DJ; Furman MI; Michelson AD
    Circulation; 2009 Dec; 120(25):2586-96. PubMed ID: 19996015
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.